Publicaciones en las que colabora con ENCARNACIÓN MORENO CALVO (16)

2015

  1. A Lactobacillus plantarum strain isolated from kefir protects against intestinal infection with Yersinia enterocolitica O9 and modulates immunity in mice

    Research in Microbiology, Vol. 166, Núm. 8, pp. 626-632

2014

  1. Lack of correlation between invitro antibiosis and invivo protection against enteropathogenic bacteria by probiotic lactobacilli

    Research in Microbiology, Vol. 165, Núm. 1, pp. 14-20

2008

  1. Telithromycin inhibits the production of proinflammatory mediators and the activation of NF-κB in in vitro-stimulated murine cells

    FEMS Immunology and Medical Microbiology, Vol. 53, Núm. 3, pp. 343-350

2007

  1. A probiotic strain of Lactobacillus plantarum stimulates lymphocyte responses in immunologically intact and immunocompromised mice

    International Journal of Food Microbiology, Vol. 113, Núm. 1, pp. 28-34

  2. The anti-inflammatory activity of telithromycin in a mouse model of septic shock

    International Journal of Antimicrobial Agents

2006

  1. A selective differential medium for Lactobacillus plantarum

    Journal of Microbiological Methods, Vol. 66, Núm. 3, pp. 572-575

2005

  1. Immunomodulation by non-absorbable antibiotics given by the intragastric route

    International Journal of Antimicrobial Agents, Vol. 25, Núm. 3, pp. 252-255

2004

  1. In vivo immunomodulation by Mycoplasma fermentans membrane lipoprotein

    Current Microbiology, Vol. 48, Núm. 3, pp. 237-239

2003

  1. Immunomodulation by Yersinia enterocolitica: Comparison of live and heat-killed bacteria

    FEMS Immunology and Medical Microbiology, Vol. 39, Núm. 3, pp. 229-233

  2. Modification of mitogen-driven lymphoproliferation by ceftriaxone in normal and immunocompromised mice

    International Journal of Antimicrobial Agents, Vol. 22, Núm. 6, pp. 607-612

2001

  1. Biological response modifier activity of an exopolysaccharide from Paenibacillus jamilae CP-7

    Clinical and Diagnostic Laboratory Immunology, Vol. 8, Núm. 4, pp. 706-710

  2. Intestinal infection of BALB/c mice with Yersinia enterocolitica 09 causes major modifications in phenotype and functions of spleen cells

    Microbiology, Vol. 147, Núm. 11, pp. 3165-3169

1999

  1. Experimental infection of mice with Yersinia enterocolitica serotype O9 by oral and parenteral routes: Spreading and enterotropism of virulent Yersiniae

    Current Microbiology, Vol. 38, Núm. 5, pp. 257-263

1998

  1. Comparison of ceftriaxone, amikacin, and ciprofloxacin in treatment of experimental Yersinia enterocolitica O9 infection in mice

    Antimicrobial Agents and Chemotherapy, Vol. 42, Núm. 11, pp. 3009-3011

1995

  1. Modification of immune response in mice by ciprofloxacin

    Antimicrobial Agents and Chemotherapy, Vol. 39, Núm. 1, pp. 150-154

1994

  1. Chromosome-mediated resistance of Yersinia enterocolitica serotype O9 to intracellular killing by mouse peritoneal macrophages

    FEMS Immunology and Medical Microbiology, Vol. 9, Núm. 4, pp. 317-324